The evolving standard of care for advanced/recurrent endometrial cancer: A practice-focused discussion of immunotherapy

touchIN CONVERSATION for touchONCOLOGY

Listen to two expert gynaecologic oncology specialists discuss the evolving role of immunotherapy in the treatment of advanced/recurrent endometrial cancer. They explore how immune checkpoint inhibitors are reshaping standards of care across lines of therapy, highlight key practical considerations for optimizing patient selection and management, and examine emerging data that may influence future treatment paradigms.

The experts

• Dr Alexandra Leary, Gustave Roussy Cancer Center, Villejuif, France
• Dr Juan Francisco Grau, Gustave Roussy Cancer Center, Villejuif, France

This touchPODCAST is for HCPs outside of the USA and UK only. 

This activity is funded by an independent medical education grant from GSK.

This activity is provided by touchIME. touchIME is an EBAC® accredited provider.

For further information visit our website: https://touchoncologyime.org/